A cross-sectional study of 626 surgical head and neck cancer patients in China finds that higher nutritional knowledge and ...

Plasma-derived small extracellular vesicles from head and neck cancer patients suppress T-cell proliferation, trigger ...

BioNTech's cancer pipeline is bigger than its COVID-era reputation suggests, and the stock still trades below $100.

ABBV's Temab-A wins two FDA Breakthrough Therapy designations for treating colorectal cancer and non-small cell lung cancer.

Dr Imogen Brooks, a cancer survivor from London, has become the first person in the United Kingdom to receive a bespoke ...

Dr Imogen Brooks was diagnosed with a squamous cell carcinoma, the most common type of head and neck cancer, when she was ...

A man from England who was diagnosed as a quadriplegic after breaking his neck while swimming with his children has begun to ...

New Research on Neoadjuvant Alpelisib and Biomarkers in Head and Neck Cancer / Adrian Mendez, Andrew Warner, Anthony C. Nichols, Anthony Nichols, ...

Dr Imogen Brooks was left despairing around three years ago after surgery left her without most of her tongue - and ...

PMV Pharmaceuticals is rated Buy, targeting $3–$4/share, driven by Rezatapopt's 46% response rate. Click to read more about ...

The late Tuggle was an NFL player who died of cancer at the height of his career Krumholtz was diagnosed with aggressive ...

Dan Costin, MD, discusses where personalized mRNA vaccines could fit into lung cancer care within 5 to 10 years. Dan Costin, ...